TrialBlood cancer journal2018

Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma.

Shaji K Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.